Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pim van der Harst

Showing results (31-40 of 666) with videos related to

Pageof 67
Sort By:
STAR Protocols|June 30, 2022
ukbpheno v1.0: An R package for phenotyping health-related outcomes in the UK BiobankMing Wai Yeung, Pim van der Harst, Niek Verweij
European Journal of Heart Failure|April 2, 2015
HFpEF vs. HFrEF: can microRNAs advance the diagnosis?Daniela Schmitter, Adriaan A Voors, Pim van der Harst
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 13, 2017
Urine albumin excretion and the risk of incident atrial fibrillation: predictive or aetiological relevance-Authors' replyAnne H Hobbelt, Pim Van Der Harst, Michiel Rienstra
Journal of the American College of Cardiology|February 25, 2017
Reply: Poor Sensitivity and Specificity of Electrocardiographic Estimation of Myocardial MassPim van der Harst, Paul I W de Bakker
European Journal of Preventive Cardiology|July 30, 2021
Validation and comparison of 28 risk prediction models for coronary artery diseaseChris Lenselink, Daan Ties, Rick Pleijhuis, et al.
Circulation|November 5, 2008
Letter by Huzen et al regarding article, "Association of leukocyte telomere length with circulating biomarkers of the renin-angiotensin-aldosterone system: the Framingham Heart Study"Jardi Huzen, Dirk J van Veldhuisen, Pim van der Harst
Journal of the American College of Cardiology|November 13, 2020
Preemptive Stenting of the Vulnerable Plaque: Fixing a Dogma?Gerard Pasterkamp, Pim van der Harst, Hester M den Ruijter
European Heart Journal|January 9, 2024
Tackling cardiovascular healthcare disparities for LGBTQIA+ population: a call to action in the European Society of CardiologyAlexander Kharlamov, Nigel Sherriff, Christian Delles, et al.
JAMA|July 9, 2004
Aggressive lipid-lowering therapy and regression of coronary atheromaPim van der Harst, Wiek H van Gilst, Felix Zijlstra
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 2, 2010
Dissecting the genetics of complex traits: lessons from hypertensionGerjan Navis, Stephan J L Bakker, Pim van der Harst
Pageof 67

Showing results (31-40 of 666) with videos related to

Sort By:
Pageof 67
STAR Protocols|June 30, 2022
ukbpheno v1.0: An R package for phenotyping health-related outcomes in the UK BiobankMing Wai Yeung, Pim van der Harst, Niek Verweij
European Journal of Heart Failure|April 2, 2015
HFpEF vs. HFrEF: can microRNAs advance the diagnosis?Daniela Schmitter, Adriaan A Voors, Pim van der Harst
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 13, 2017
Urine albumin excretion and the risk of incident atrial fibrillation: predictive or aetiological relevance-Authors' replyAnne H Hobbelt, Pim Van Der Harst, Michiel Rienstra
Journal of the American College of Cardiology|February 25, 2017
Reply: Poor Sensitivity and Specificity of Electrocardiographic Estimation of Myocardial MassPim van der Harst, Paul I W de Bakker
European Journal of Preventive Cardiology|July 30, 2021
Validation and comparison of 28 risk prediction models for coronary artery diseaseChris Lenselink, Daan Ties, Rick Pleijhuis, et al.
Circulation|November 5, 2008
Letter by Huzen et al regarding article, "Association of leukocyte telomere length with circulating biomarkers of the renin-angiotensin-aldosterone system: the Framingham Heart Study"Jardi Huzen, Dirk J van Veldhuisen, Pim van der Harst
Journal of the American College of Cardiology|November 13, 2020
Preemptive Stenting of the Vulnerable Plaque: Fixing a Dogma?Gerard Pasterkamp, Pim van der Harst, Hester M den Ruijter
European Heart Journal|January 9, 2024
Tackling cardiovascular healthcare disparities for LGBTQIA+ population: a call to action in the European Society of CardiologyAlexander Kharlamov, Nigel Sherriff, Christian Delles, et al.
JAMA|July 9, 2004
Aggressive lipid-lowering therapy and regression of coronary atheromaPim van der Harst, Wiek H van Gilst, Felix Zijlstra
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 2, 2010
Dissecting the genetics of complex traits: lessons from hypertensionGerjan Navis, Stephan J L Bakker, Pim van der Harst
Pageof 67